|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09995 REMEGEN
Nominal 
78.700 -2.250 (-2.779%) Ranking Overview
Ranking based on 12 research report(s)
Average Ranking 2.25
|
Strong Buy (1)
0
|
Buy (2)
9
|
Hold (3)
3
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -273.00 RMB (cts) | |
| Net Profit | -1,468.36 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | -263.50 | -44.50 | 0 | -- | -99.00 | -383.00 |
| 2026 | 34.00 | 6.00 | 0 | -- | 4,068.00 | -354.00 |
| 2027 | 849.00 | 155.25 | 0 | -- | 1,060.00 | -1.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | -345.54 | -61.00 | -- | HUATAI FIN HLDGS HK | Buy | 139.96 | 19/10/2025 | |
| 2025 | -164.00 | -30.00 | -- | UBS | Buy | 120.00 | 30/01/2026 | |
| 2025 | -147.00 | -26.60 | -- | CCBI | OutPerform | 120.00 | 14/11/2025 | |
| 2025 | -261.00 | -46.00 | -- | CITIC SEC | Buy | 117.00 | 21/01/2026 | |
| 2025 | -266.00 | -43.00 | -- | JP MORGAN | Overweight | 116.00 | 13/01/2026 | |
| 2025 | -99.00 | -18.70 | -- | BOCOM | Buy | 112.00 | 31/10/2025 | |
| 2025 | -345.00 | -61.00 | -- | CICC | Outperform | 105.44 | 28/08/2025 | |
| 2025 | -383.00 | -67.80 | -- | CITIGROUP | Buy | 105.00 | 04/02/2026 | |
| 2025 | -173.00 | -31.00 | -- | CLSA | OutPerform | 103.00 | 26/08/2025 | |
| 2025 | -122.00 | -21.70 | -- | BOCI | Hold | 90.00 | 26/08/2025 | |
| 2025 | -277.00 | -50.00 | -- | MORGAN STANLEY | Equal-weight | 89.00 | 30/10/2025 | |
| 2025 | -338.00 | -61.00 | -- | ZHONGTAI INT'L SEC | Neutral | 85.50 | 26/08/2025 | |
| 2026 | 3,774.00 | 670.00 | -- | UBS | - | -- | 30/01/2026 | |
| 2026 | 3.00 | 0.60 | -- | CCBI | - | -- | 14/11/2025 | |
| 2026 | 3,432.00 | 609.00 | -- | CITIC SEC | - | -- | 21/01/2026 | |
| 2026 | 3,849.00 | 697.00 | -- | JP MORGAN | - | -- | 13/01/2026 | |
| 2026 | 47.00 | 8.90 | -- | BOCOM | - | -- | 31/10/2025 | |
| 2026 | 34.00 | 6.00 | -- | CICC | - | -- | 28/08/2025 | |
| 2026 | 4,068.00 | 721.20 | -- | CITIGROUP | - | -- | 04/02/2026 | |
| 2026 | 10.00 | 2.00 | -- | CLSA | - | -- | 26/08/2025 | |
| 2026 | -39.00 | -6.90 | -- | BOCI | - | -- | 26/08/2025 | |
| 2026 | -354.00 | -63.00 | -- | MORGAN STANLEY | - | -- | 30/10/2025 | |
| 2026 | -354.00 | -63.00 | -- | ZHONGTAI INT'L SEC | - | -- | 26/08/2025 | |
| 2027 | 855.00 | 151.80 | -- | CCBI | - | -- | 14/11/2025 | |
| 2027 | 202.00 | 36.00 | -- | UBS | - | -- | 30/01/2026 | |
| 2027 | 979.00 | 174.00 | -- | CITIC SEC | - | -- | 21/01/2026 | |
| 2027 | 926.00 | 168.00 | -- | JP MORGAN | - | -- | 13/01/2026 | |
| 2027 | 843.00 | 158.70 | -- | BOCOM | - | -- | 31/10/2025 | |
| 2027 | -1.00 | -0.20 | -- | CITIGROUP | - | -- | 04/02/2026 | |
| 2027 | 1,060.00 | 188.00 | -- | CLSA | - | -- | 26/08/2025 | |
| 2027 | 1,054.00 | 187.10 | -- | BOCI | - | -- | 26/08/2025 | |
| 2027 | 116.00 | 21.00 | -- | MORGAN STANLEY | - | -- | 30/10/2025 | |
| 2027 | 437.00 | 78.00 | -- | ZHONGTAI INT'L SEC | - | -- | 26/08/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 06/02/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -449,568 |
| %Change | -42.397% |
| EPS / (LPS) | RMB -0.830 |
| NBV Per Share (¥) | RMB 4.183 |